>Marché de l'IRM cérébrale en Asie-Pacifique, par type de scanner (faible intensité de champ (IRM sclérose en plaques et autres), utilisateur final (hôpitaux, centres d'imagerie et de diagnostic, centres de chirurgie ambulatoire et autres), canal de distribution (appel d'offres direct, vente au détail), pays (Chine, Inde, Japon, Corée du Sud, Australie, Singapour, Thaïlande, Malaisie, Indonésie, Philippines et reste de l'Asie-Pacifique) Tendances et prévisions de l'industrie jusqu'en 2029.
Analyse et perspectives du marché : marché de l'imagerie par résonance magnétique cérébrale en Asie-Pacifique
L'IRM cérébrale est un trouble neurologique rare dans lequel le cerveau d'un enfant se développe de manière anormale pendant la grossesse. Il se développe en raison d'un défaut de migration neuronale qui se produit entre 12 et 24 semaines de gestation, ce qui entraîne l'absence de développement normal des circonvolutions et des sillons cérébraux. Une sonde de gastrostomie est insérée dans l'estomac des enfants souffrant de difficultés d'alimentation et de déglutition. Selon les recherches, elle peut être causée par un dysfonctionnement de plusieurs gènes. La majorité de ces altérations génétiques ne sont pas toujours héritées des parents. Lorsqu'il n'y a pas d'antécédents familiaux de la maladie, elles peuvent apparaître de manière aléatoire dans la constitution génétique d'une personne.
L'IRM cérébrale en Asie-Pacifique est un outil de soutien et vise à réduire la gravité des symptômes. Data Bridge Market Research analyse que le marché de l'IRM cérébrale en Asie-Pacifique connaîtra une croissance de 5,6 % au cours de la période de prévision de 2022 à 2029.
|
Rapport métrique |
Détails |
|
Période de prévision |
2022 à 2029 |
|
Année de base |
2021 |
|
Années historiques |
2020 (personnalisable de 2019 à 2014) |
|
Unités quantitatives |
Chiffre d'affaires en millions USD, prix en USD |
|
Segments couverts |
Par type de scanner (faible intensité de champ (IRM < 1,5 t), intensité de champ moyenne (IRM 1,5 t à IRM 3,0 t et intensité de champ élevée (4 t et plus)), type de machine (machine IRM ouverte, machine IRM fermée et machine IRM debout ou assise), type de trouble cérébral (tumeur cérébrale, démence, maladie d'Alzheimer, maladie de Parkinson, épilepsie et crise, accident vasculaire cérébral, sclérose en plaques et autres), utilisateur final (hôpitaux, centres d'imagerie et de diagnostic, centres de chirurgie ambulatoire et autres), canal de distribution (appel d'offres direct, vente au détail) |
|
Pays couverts |
Chine, Inde, Japon, Corée du Sud, Australie, Singapour, Thaïlande, Malaisie, Indonésie, Philippines et reste de l'Asie-Pacifique |
|
Acteurs du marché couverts |
Koninklijke Philips N.V. Voxelgrids, General Electric Company, Time Medical Holding., FUJIFILM Holdings America Corporation, Siemens Healthcare GmbH, CANON MEDICAL SYSTEMS CORPORATION, ESAOTE SPA, Beijing Wandong Medical Technology Co.,Ltd., Shenzhen Anke High-tech Co, Ltd., StemLab, Inc.,UNITED IMAGING, BASDA, Neusoft Corporation, MinFound Medical Systems Co., Elekta AB, Bruker, Aspect Imaging Ltd., Medonica Co. LTD among others |
Asia-Pacific Brain MRI Scan Market Dynamics
Drivers
- Rise incidence of Alzheimer’s in China, suffering from dementia
The rise in patient population, in China would increase the use and availability of the MRI scan instruments in imaging and diagnostic center and hence act as a major driver that will result in the expansion of the growth rate of the market.
- Awareness among population about the treatment and use of brain scan MRI devices
Another significant factor influencing the growth rate of the Asia-Pacific brain MRI scan market is to instill awareness about the timely treatment for neurological disorders, which will boost the use of brain MRI scan instruments
- Favorable reimbursement policies
Also, the increase in the growth, are the favourable reimbursement policies being implemented, which will further enhance the growth of the Asia-Pacific brain MRI scan market.
Furthermore, advancement in medical technology, rising initiatives by public and private organizations to spread awareness and growing government funding are the factors that will expand the rain MRI scan market. Other factors such as increase in the demand for effective therapies and rising awareness about the timely diagnosis and will positively impact the Asia-Pacific brain MRI scan market's growth rate. Additionally, high disposable income, rising number of cases of seizures and changing lifestyle will result in the expansion of the Asia-Pacific brain MRI scan market.
Opportunities
- The rise in healthcare expenditure
Moreover, the rise in the research and development activities and increasing investments by government and private organization will boost new opportunities for the market's growth rate.
For instance,
- According to the data by Eurostat, in 2019, the healthcare expenditure was highest in France and Germany. Among the EU Member States, Germany (11.7 %) and France (11.1 %) had the highest healthcare expenditure relative to GDP in 2019
Also, the launch of effective therapies and continuous clinical trials will provide beneficial opportunities for the Asia-Pacific brain MRI scan market in the forecast period of 2022-2029. Also, high unmet need of current and developments in healthcare technology will escalate the growth rate of the Asia-Pacific brain MRI scan market in future.
Restraints/Challenges
However, high cost associated with the available and lack of infrastructure in low-income countries will impede the growth rate of Asia-Pacific brain MRI scan market. Additionally, the risks incurred while using the MRI devices will hinder the Asia-Pacific brain MRI scan market growth. The lack of cure for this neurological condition and less awareness about genetic and rare diseases will further challenge the market in the forecast period mentioned above. The availability of alternate imaging diagnostic devices, would result in a decline in sales of the devices, surgery, consumables, and accessories in poor economy countries
The Asia-Pacific brain MRI scan market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on Asia-Pacific brain MRI scan market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Patient Epidemiology Analysis
Asia-Pacific brain MRI scan is a brain disorder that is relatively uncommon and whose incidence is unknown. In 2019, the data by the Neuroscience Network in Australia stated that, the total prevalence for neurological disorders in 2017 accounted for 10.6 million people or 43 per cent of Australian population, followed by mental health disorders of 4 million people (16.3 %) and substance disorders of 0.8 million people (3.2%).
Asia-Pacific brain MRI scan market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Covid-19 Impact on the Asia-Pacific Brain MRI Scan Market
The COVID-19 has negatively affected the market. Lockdowns and isolation during pandemics complicate the diagnosis management and treatment. The lack of access to health-care facilities for routine and medication administration will further affect the market.
However, the use of artificial intelligence, had improved the MRI scan market, backed by the European Union. The artificial intelligence MRI scanners are used to scan around 20,000 CT scans.
Recent Development
- En mai 2021, GE Healthcare a annoncé qu'AIR Recon DL, une société basée sur l'IRM à ultra-haut champ et l'IA, a reçu l'autorisation 510(k) de la FDA sur les scanners d'imagerie par résonance magnétique (IRM) SIGNA 7.0T pour une confiance diagnostique avec une meilleure qualité d'image. Cette approbation de produit augmentera les revenus de l'entreprise sur le marché
Portée du marché de l'imagerie par résonance magnétique cérébrale en Asie-Pacifique
Le marché de l'imagerie par résonance magnétique cérébrale en Asie-Pacifique est segmenté en fonction du type de scanner, du type de machine, du trouble cérébral, des utilisateurs finaux et du canal de distribution. La croissance parmi ces segments vous aidera à analyser les segments de croissance faibles dans les industries et à fournir aux utilisateurs un aperçu précieux du marché et des informations sur le marché pour les aider à prendre des décisions stratégiques pour identifier les principales applications du marché.
Type de scanner
- Faible intensité de champ (IRM < 1,5 T)
- Intensité de champ moyenne (IRM de 1,5 T à IRM de 3,0 T)
- Intensité de champ élevée (4T et plus)
Sur la base du type de scanner , le marché de l'IRM cérébrale en Asie-Pacifique est segmenté en faible intensité de champ (IRM < 1,5 T), intensité de champ moyenne (IRM 1,5 T à IRM 3,0 T) et intensité de champ élevée (4 T et plus).
Type de machine
- Machine IRM ouverte
- Machine IRM fermée
- Appareil d'IRM debout ou assis
Sur la base du type de machine, le marché de l'IRM cérébrale en Asie-Pacifique est segmenté en machine d'IRM ouverte, machine d'IRM fermée et machine d'IRM debout ou assise.
Trouble cérébral
- Tumeur cérébrale
- Démence
- Maladie d'Alzheimer
- Maladie de Parkinson
- Épilepsie et crises d'épilepsie
- Accident vasculaire cérébral
- Sclérose en plaques
- Autres
Sur la base des troubles cérébraux, le marché de l'IRM cérébrale en Asie-Pacifique est segmenté en tumeur cérébrale, démence, maladie d'Alzheimer , maladie de Parkinson, épilepsie et crises, accident vasculaire cérébral, sclérose en plaques et autres.
Utilisateur final
- Hôpitaux
- Centres d'imagerie et de diagnostic
- Centres de chirurgie ambulatoire
- Autres
Sur la base de l'utilisateur final, le marché de l'IRM cérébrale en Asie-Pacifique est segmenté en hôpitaux, centres d'imagerie et de diagnostic, centres de chirurgie ambulatoire et autres.
Canal de distribution
- Appels d'offres directs
- Ventes au détail
Sur la base du canal de distribution, le marché de l'IRM cérébrale en Asie-Pacifique est segmenté en appels d'offres directs et ventes au détail.
Analyse du pipeline (non fournie)
Analyse/perspectives du marché de l'imagerie par résonance magnétique cérébrale en Asie-Pacifique
Le marché de l’IRM cérébrale en Asie-Pacifique est analysé et des informations sur la taille du marché et les tendances sont fournies par pays, type de scanner, type de machine, trouble cérébral, utilisateurs finaux et canal de distribution, comme référencé ci-dessus.
Les pays couverts dans le rapport sur le marché de l'IRM cérébrale en Asie-Pacifique sont la Chine, l'Inde, le Japon, la Corée du Sud, l'Australie, Singapour, la Thaïlande, la Malaisie, l'Indonésie, les Philippines et le reste de l'Asie-Pacifique.
Le Japon domine le marché de l'IRM cérébrale en Asie-Pacifique en termes de part de marché et de chiffre d'affaires et continuera de renforcer sa domination au cours de la période de prévision. Cela est dû à la présence d'acteurs clés majeurs et d'infrastructures de santé bien développées dans cette région et au partenariat avec les acteurs du marché de la région Asie-Pacifique pour la fourniture et la distribution des appareils d'IRM.
La section pays du rapport fournit également des facteurs d'impact sur les marchés individuels et des changements de réglementation sur le marché national qui ont un impact sur les tendances actuelles et futures du marché. Des points de données tels que les nouvelles ventes, les ventes de remplacement, la démographie des pays, l'épidémiologie des maladies et les tarifs d'importation et d'exportation sont quelques-uns des principaux indicateurs utilisés pour prévoir le scénario de marché pour les différents pays. En outre, la présence et la disponibilité des marques d'Asie-Pacifique et les défis auxquels elles sont confrontées en raison de la concurrence importante ou rare des marques locales et nationales, l'impact des canaux de vente sont pris en compte lors de l'analyse prévisionnelle des données nationales.
Analyse du paysage concurrentiel et des parts de marché du marché de l'imagerie par résonance magnétique cérébrale en Asie-Pacifique
Le paysage concurrentiel du marché de l'IRM cérébrale en Asie-Pacifique fournit des détails par concurrent. Les détails inclus sont la présentation de l'entreprise, les finances de l'entreprise, les revenus générés, le potentiel du marché, les investissements dans la recherche et le développement, les nouvelles initiatives du marché, la présence en Asie-Pacifique, les sites et installations de production, les capacités de production, les forces et les faiblesses de l'entreprise, le lancement du produit, la largeur et l'étendue du produit, la domination des applications. Les points de données ci-dessus fournis ne concernent que l'orientation des entreprises liées au marché de l'IRM cérébrale en Asie-Pacifique.
Français Certains des principaux acteurs opérant sur le marché de l'IRM cérébrale en Asie-Pacifique sont Koninklijke Philips NV Voxelgrids, General Electric Company, Time Medical Holding., FUJIFILM Holdings America Corporation, Siemens Healthcare GmbH, CANON MEDICAL SYSTEMS CORPORATION, ESAOTE SPA, Beijing Wandong Medical Technology Co., Ltd., Shenzhen Anke High-tech Co, Ltd., StemLab, Inc., UNITED IMAGING, BASDA, Neusoft Corporation, MinFound Medical Systems Co., Elekta AB, Bruker, Aspect Imaging Ltd., Medonica Co. LTD entre autres.
SKU-
Accédez en ligne au rapport sur le premier cloud mondial de veille économique
- Tableau de bord d'analyse de données interactif
- Tableau de bord d'analyse d'entreprise pour les opportunités à fort potentiel de croissance
- Accès d'analyste de recherche pour la personnalisation et les requêtes
- Analyse de la concurrence avec tableau de bord interactif
- Dernières actualités, mises à jour et analyse des tendances
- Exploitez la puissance de l'analyse comparative pour un suivi complet de la concurrence
Table des matières
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA PACIFIC BRAIN MRI SCAN MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 ASIA PACIFIC BRAIN MRI SCAN MARKET: SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT SEGMENT LIFELINE CURVE
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 MARKET END USER COVERAGE GRID
2.11 SECONDARY SOURCES
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTERS FIVE FORCES
4.3 NUMER OF PATIENTS GETTING PERIODIC HEALTH EXAMINATIONS (PHE) USING MRI
5 ASIA PACIFIC BRAIN MRI SCAN MARKET: REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 RISE IN PREVALENCE AND INCIDENCE OF NEUROLOGICAL DISORDERS
6.1.2 AWARENESS AMONG POPULATION ABOUT THE TREATMENT AND USE OF BRAIN SCAN MRIDEVICES
6.1.3 TECHNOLOGICAL ADVANCEMENTS IN BRAIN MAGNETIC RESONANCE IMAGING (MRI) SCAN DEVICES
6.1.4 FAVORABLE REIMBURSEMENT POLICIES
6.1.5 RISE IN PRODUCT APPROVALS
6.2 RESTRAINTS
6.2.1 RISE IN COST OF THE MAGNETIC RESONANCE IMAGING (MRI) SCAN DEVICES
6.2.2 RISKS NOTICED WHILE USING MAGNETIC RESONANCE IMAGING (MRI) SCAN DEVICES
6.2.3 RISE IN PRODUCT RECALL
6.2.4 AVAILABILITY OF ALTERNATE IMAGING DIAGNOSTIC DEVICES
6.3 OPPORTUNITIES
6.3.1 STRATEGIC INITIATIVES BY MARKET PLAYERS
6.3.2 RISE IN HEALTHCARE EXPENDITURE
6.3.3 INCREASE IN DEMAND FOR NON-INVASIVE MAGNETIC RESONANCE IMAGING (MRI) SCAN DEVICES
6.4 CHALLENGES
6.4.1 LACK OF SKILLED PROFESSIONALS REQUIRED FOR USE OF BRAIN MRI SCAN DEVICES
6.4.2 STRINGENT REGULATIONS
7 ASIA PACIFIC BRAIN MRI SCAN MARKET, BY SCANNER TYPE
7.1 OVERVIEW
7.2 MID FIELD STRENGTH (1.5T MRI TO 3.0T MRI)
7.2.1 FIELD STRENGTH 1.5T
7.2.2 FIELD STRENGTH 3T
7.3 LOW FIELD STRENGTH (<1.5T MRI)
7.4 HIGH FIELD STRENGTH (4T AND ABOVE)
8 ASIA PACIFIC BRAIN MRI SCAN MARKET, BY MACHINE TYPE
8.1 OVERVIEW
8.2 CLOSED MRI MACHINE
8.3 OPEN MRI MACHINE
8.4 STANDING OR SITTING MRI MACHINE
9 ASIA PACIFIC BRAIN MRI SCAN MARKET, BY BRAIN DISORDER
9.1 OVERVIEW
9.2 DEMENTIA
9.2.1 BY MACHINE TYPE
9.2.1.1 CLOSED MRI MACHINE
9.2.1.2 OPEN MRI MACHINE
9.2.1.3 STANDING OR SITTING MRI MACHINE
9.3 ALZHEIMER'S DISEASE
9.3.1 BY MACHINE TYPE
9.3.1.1 CLOSED MRI MACHINE
9.3.1.2 OPEN MRI MACHINE
9.3.1.3 STANDING OR SITTING MRI MACHINE
9.4 EPILEPSY AND SEIZURE
9.4.1 BY MACHINE TYPE
9.4.1.1 CLOSED MRI MACHINE
9.4.1.2 OPEN MRI MACHINE
9.4.1.3 STANDING OR SITTING MRI MACHINE
9.5 PARKINSON'S DISEASE
9.5.1 BY MACHINE TYPE
9.5.1.1 CLOSED MRI MACHINE
9.5.1.2 OPEN MRI MACHINE
9.5.1.3 STANDING OR SITTING MRI MACHINE
9.6 STROKE
9.6.1 BY MACHINE TYPE
9.6.1.1 CLOSED MRI MACHINE
9.6.1.2 OPEN MRI MACHINE
9.6.1.3 STANDING OR SITTING MRI MACHINE
9.7 MULTIPLE SCLEROSIS
9.7.1 BY MACHINE TYPE
9.7.1.1 CLOSED MRI MACHINE
9.7.1.2 OPEN MRI MACHINE
9.7.1.3 STANDING OR SITTING MRI MACHINE
9.8 BRAIN TUMOR
9.8.1 BY MACHINE TYPE
9.8.1.1 CLOSED MRI MACHINE
9.8.1.2 OPEN MRI MACHINE
9.8.1.3 STANDING OR SITTING MRI MACHINE
9.9 OTHER BRAIN DISORDERS
10 ASIA PACIFIC BRAIN MRI SCAN MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.3 IMAGING DIAGNOSTIC CENTERS
10.4 AMBULATORY SURGERY CENTERS
10.5 OTHERS
11 ASIA PACIFIC BRAIN MRI SCAN MARKET, BY DISTRIBUTION CHANNEL
11.1 OVERVIEW
11.2 DIRECT TENDER
11.3 RETAIL SALES
12 ASIA PACIFIC BRAIN MRI SCAN MARKET, BY REGION
12.1 ASIA-PACIFIC
12.1.1 JAPAN
12.1.2 CHINA
12.1.3 SOUTH KOREA
12.1.4 INDIA
12.1.5 AUSTRALIA
12.1.6 THAILAND
12.1.7 SINGAPORE
12.1.8 MALAYSIA
12.1.9 INDONESIA
12.1.10 PHILIPPINES
12.1.11 REST OF ASIA PACIFIC
13 ASIA PACIFIC BRAIN MRI SCAN MARKET: COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: ASIA PACIFIC
14 SWOT ANALYSIS
15 COMPANY PROFILE
15.1 SIEMENS AG
15.1.1 COMPANY SNAPSHOT
15.1.2 REVENUE ANALYSIS
15.1.3 COMPANY SHARE ANALYSIS
15.1.4 PRODUCT PORTFOLIO
15.1.5 RECENT DEVELOPMENTS
15.1.5.1 ACQUISITION
15.2 GENERAL ELECTRIC COMPANY
15.2.1 COMPANY SNAPSHOT
15.2.2 REVENUE ANALYSIS
15.2.3 COMPANY SHARE ANALYSIS
15.2.4 PRODUCT PORTFOLIO
15.2.5 RECENT DEVELOPMENTS
15.2.5.1 PRODUCT APPROVAL
15.3 CANON MEDICAL SYSTEMS CORPORATION (A SUBSIDIARY OF CANON INC.)
15.3.1 COMPANY SNAPSHOT
15.3.2 REVENUE ANALYSIS
15.3.3 COMPANY SHARE ANALYSIS
15.3.4 PRODUCT PORTFOLIO
15.3.5 RECENT DEVELOPMENTS
15.4 KONINKLIJKE PHILIPS N.V
15.4.1 COMPANY SNAPSHOT
15.4.2 REVENUE ANALYSIS
15.4.3 COMPANY SHARE ANALYSIS
15.4.4 PRODUCT PORTFOLIO
15.4.5 RECENT DEVELOPMENT
15.5 FUJIFILM HOLDINGS AMERICA CORPORATION (2021)
15.5.1 COMPANY SNAPSHOT
15.5.2 REVENUE ANALYSIS
15.5.3 COMPANY SHARE ANALYSIS
15.5.4 PRODUCT PORTFOLIO
15.5.5 RECENT DEVELOPMENT
15.6 ELEKTA AB
15.6.1 COMPANY SNAPSHOT
15.6.2 REVENUS ANALYSIS
15.6.3 PRODUCT PORTFOLIO
15.6.4 RECENT DEVELOPMENTS
15.7 ALLTECH MEDICAL SYSTEMS
15.7.1 COMPANY SNAPSHOT
15.7.2 PRODUCT PORTFOLIO
15.7.3 RECENT DEVELOPMENTS
15.8 ASPECT IMAGING
15.8.1 COMPANY SNAPSHOT
15.8.2 PRODUCT PORTFOLIO
15.8.3 RECENT DEVELOPMENT
15.9 ASG SUPERCONDUCTORS SPA
15.9.1 COMPANY SNAPSHOT
15.9.2 PRODUCT PORTFOLIO
15.9.3 RECENT DEVELOPMENT
15.1 BRUKER (2021)
15.10.1 COMPANY SNAPSHOT
15.10.2 REVENUE ANALYSIS
15.10.3 PRODUCT PORTFOLIO
15.10.4 RECENT DEVELOPMENT
15.11 BASDA
15.11.1 COMPANY SNAPSHOT
15.11.2 PRODUCT PORTFOLIO
15.11.3 RECENT DEVELOPMENT
15.12 BEIJING WANDONG MEDICAL TECHNOLOGY CO.,LTD (2021)
15.12.1 COMPANY SNAPSHOT
15.12.2 PRODUCT PORTFOLIO
15.12.3 RECENT DEVELOPMENTS
15.13 ESAOTE SPA
15.13.1 COMPANY SNAPSHOT
15.13.2 PRODUCT PORTFOLIO
15.13.3 RECENT DEVELOPMENT
15.13.3.1 PRODUCT APPROVAL
15.14 FONAR CORP.
15.14.1 COMPANY SNAPSHOT
15.14.2 REVENUS ANALYSIS
15.14.3 PRODUCT PORTFOLIO
15.14.4 RECENT DEVELOPMENT
15.15 HYPERFINE
15.15.1 COMPANY SNAPSHOT
15.15.2 PRODUCT PORTFOLIO
15.15.3 RECENT DEVELOPMENT
15.16 MINFOUND MEDICAL SYSTEMS CO.
15.16.1 COMPANY SNAPSHOT
15.16.2 PRODUCT PORTFOLIO
15.16.3 RECENT DEVELOPMENT
15.17 MEDONICA CO. LTD
15.17.1 COMPANY SNAPSHOT
15.17.2 PRODUCT PORTFOLIO
15.17.3 RECENT DEVELOPMENTS
15.18 NEUSOFT MEDICAL SYSTEMS
15.18.1 COMPANY SNAPSHOT
15.18.2 PRODUCT PORTFOLIO
15.18.3 RECENT DEVELOPMENT
15.19 STEMLAB, INC.
15.19.1 COMPANY SNAPSHOT
15.19.2 PRODUCT PORTFOLIO
15.19.3 RECENT DEVELOPMENT
15.2 STERNMED GMBH
15.20.1 COMPANY SNAPSHOT
15.20.2 PRODUCT PORTFOLIO
15.20.3 RECENT DEVELOPMENTS
15.21 SYNAPTIVE MEDICAL
15.21.1 COMPANY SNAPSHOT
15.21.2 PRODUCT PORTFOLIO
15.21.3 RECENT DEVELOPMENT
15.22 SHENZHEN ANKE HIGH-TECH CO., LTD.
15.22.1 COMPANY SNAPSHOT
15.22.2 PRODUCT PORTFOLIO
15.22.3 RECENT DEVELOPMENT
15.23 TIME MEDICAL HOLDING
15.23.1 COMPANY SNAPSHOT
15.23.2 PRODUCT PORTFOLIO
15.23.3 RECENT DEVELOPMENTS
15.24 VOXELGRIDS
15.24.1 COMPANY SNAPSHOT
15.24.2 PRODUCT PORTFOLIO
15.24.3 RECENT DEVELOPMENTS
15.25 UNITED IMAGING
15.25.1 COMPANY SNAPSHOT
15.25.2 PRODUCT PORTFOLIO
15.25.3 RECENT DEVELOPMENT
15.26 ULTRAVISION MEDICAL EQUIPMENT TRADING L.L.C
15.26.1 COMPANY SNAPSHOT
15.26.2 PRODUCT PORTFOLIO
15.26.3 RECENT DEVELOPMENTS
16 QUESTIONNAIRE
17 RELATED REPORTS
Liste des tableaux
TABLE 2 ASIA PACIFIC MID FIELD STRENGTH (1.5T MRI TO 3.0T MRI) IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 3 ASIA PACIFIC MID FIELD STRENGTH (1.5T MRI TO 3.0T MRI) IN BRAIN MRI SCAN MARKET, BY FIELD STRENGTH TYPE, 2020-2029 (USD MILLION)
TABLE 4 ASIA PACIFIC LOW FIELD STRENGTH (<1.5T MRI) IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 5 ASIA PACIFIC HIGH FIELD STRENGTH (4T AND ABOVE) IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 7 ASIA PACIFIC CLOSED MRI MACHINE IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 8 ASIA PACIFIC OPEN MRI MACHINE IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 9 ASIA PACIFIC STANDING OR SITTING MRI MACHINE IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 11 ASIA PACIFIC DEMENTIA IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 12 ASIA PACIFIC DEMENTIA IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 13 ASIA PACIFIC ALZHEIMER'S DISEASE IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 14 ASIA PACIFIC ALZHEIMER'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 15 ASIA PACIFIC EPILEPSY AND SEIZURE IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 16 ASIA PACIFIC EPILEPSY AND SEIZURE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 17 ASIA PACIFIC PARKINSON'S DISEASE IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 18 ASIA PACIFIC PARKINSON'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 19 ASIA PACIFIC STROKE IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 20 ASIA PACIFIC STROKE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 21 ASIA PACIFIC MULTIPLE SCLEROSIS IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 22 ASIA PACIFIC MULTIPLE SCLEROSIS IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 23 ASIA PACIFIC BRAIN TUMOR IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 24 ASIA PACIFIC BRAIN TUMOR IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 25 ASIA PACIFIC OTHER BRAIN DISORDERS IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 27 ASIA PACIFIC HOSPITALS IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 28 ASIA PACIFIC IMAGING DIAGNOSTIC CENTERS IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 29 ASIA PACIFIC AMBULATORY SURGERY CENTERS IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 30 ASIA PACIFIC OTHERS IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 31 ASIA PACIFIC BRAIN MRI SCAN MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 32 ASIA PACIFIC DIRECT TENDER IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 33 ASIA PACIFIC RETAIL SALES IN BRAIN MRI SCAN MARKET, BY REGION, 2020-2029 (USD MILLION)
TABLE 34 ASIA-PACIFIC BRAIN MRI SCAN MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 35 ASIA-PACIFIC BRAIN MRI SCAN MARKET, BY SCANNER TYPE, 2020-2029 (USD MILLION)
TABLE 36 ASIA-PACIFIC MID FIELD STRENGTH (1.5T MRI TO 3.0T MRI) IN BRAIN MRI SCAN MARKET, BY FIELD STRENGTH TYPE, 2020-2029 (USD MILLION)
TABLE 37 ASIA-PACIFIC BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 38 ASIA-PACIFIC BRAIN MRI SCAN MARKET, BY BRAIN DISORDER, 2020-2029 (USD MILLION)
TABLE 39 ASIA-PACIFIC DEMENTIA IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 40 ASIA-PACIFIC ALZHEIMER'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 41 ASIA-PACIFIC EPILEPSY AND SEIZURE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 42 ASIA-PACIFIC PARKINSON'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 43 ASIA-PACIFIC STROKE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 44 ASIA-PACIFIC MULTIPLE SCLEROSIS IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 45 ASIA-PACIFIC BRAIN TUMOR IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 46 ASIA-PACIFIC BRAIN MRI SCAN MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 47 ASIA-PACIFIC BRAIN MRI SCAN MARKET, BY END USER, 2020-2029 (UNIT)
TABLE 48 ASIA-PACIFIC BRAIN MRI SCAN MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 49 JAPAN BRAIN MRI SCAN MARKET, BY SCANNER TYPE, 2020-2029 (USD MILLION)
TABLE 50 JAPAN MID FIELD STRENGTH (1.5T MRI TO 3.0T MRI) IN BRAIN MRI SCAN MARKET, BY FIELD STRENGTH TYPE, 2020-2029 (USD MILLION)
TABLE 51 JAPAN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 52 JAPAN BRAIN MRI SCAN MARKET, BY BRAIN DISORDER, 2020-2029 (USD MILLION)
TABLE 53 JAPAN DEMENTIA IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 54 JAPAN ALZHEIMER'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 55 JAPAN EPILEPSY AND SEIZURE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 56 JAPAN PARKINSON'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 57 JAPAN STROKE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 58 JAPAN MULTIPLE SCLEROSIS IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 59 JAPAN BRAIN TUMOR IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 60 JAPAN BRAIN MRI SCAN MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 61 JAPAN BRAIN MRI SCAN MARKET, BY END USER, 2020-2029 (UNIT)
TABLE 62 JAPAN BRAIN MRI SCAN MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 63 CHINA BRAIN MRI SCAN MARKET, BY SCANNER TYPE, 2020-2029 (USD MILLION)
TABLE 64 CHINA MID FIELD STRENGTH (1.5T MRI TO 3.0T MRI) IN BRAIN MRI SCAN MARKET, BY FIELD STRENGTH TYPE, 2020-2029 (USD MILLION)
TABLE 65 CHINA BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 66 CHINA BRAIN MRI SCAN MARKET, BY BRAIN DISORDER, 2020-2029 (USD MILLION)
TABLE 67 CHINA DEMENTIA IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 68 CHINA ALZHEIMER'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 69 CHINA EPILEPSY AND SEIZURE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 70 CHINA PARKINSON'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 71 CHINA STROKE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 72 CHINA MULTIPLE SCLEROSIS IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 73 CHINA BRAIN TUMOR IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 74 CHINA BRAIN MRI SCAN MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 75 CHINA BRAIN MRI SCAN MARKET, BY END USER, 2020-2029 (UNIT)
TABLE 76 CHINA BRAIN MRI SCAN MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 77 SOUTH KOREA BRAIN MRI SCAN MARKET, BY SCANNER TYPE, 2020-2029 (USD MILLION)
TABLE 78 SOUTH KOREA MID FIELD STRENGTH (1.5T MRI TO 3.0T MRI) IN BRAIN MRI SCAN MARKET, BY FIELD STRENGTH TYPE, 2020-2029 (USD MILLION)
TABLE 79 SOUTH KOREA BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 80 SOUTH KOREA BRAIN MRI SCAN MARKET, BY BRAIN DISORDER, 2020-2029 (USD MILLION)
TABLE 81 SOUTH KOREA DEMENTIA IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 82 SOUTH KOREA ALZHEIMER'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 83 SOUTH KOREA EPILEPSY AND SEIZURE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 84 SOUTH KOREA PARKINSON'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 85 SOUTH KOREA STROKE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 86 SOUTH KOREA MULTIPLE SCLEROSIS IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 87 SOUTH KOREA BRAIN TUMOR IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 88 SOUTH KOREA BRAIN MRI SCAN MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 89 SOUTH KOREA BRAIN MRI SCAN MARKET, BY END USER, 2020-2029 (UNIT)
TABLE 90 SOUTH KOREA BRAIN MRI SCAN MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 91 INDIA BRAIN MRI SCAN MARKET, BY SCANNER TYPE, 2020-2029 (USD MILLION)
TABLE 92 INDIA MID FIELD STRENGTH (1.5T MRI TO 3.0T MRI) IN BRAIN MRI SCAN MARKET, BY FIELD STRENGTH TYPE, 2020-2029 (USD MILLION)
TABLE 93 INDIA BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 94 INDIA BRAIN MRI SCAN MARKET, BY BRAIN DISORDER, 2020-2029 (USD MILLION)
TABLE 95 INDIA DEMENTIA IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 96 INDIA ALZHEIMER'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 97 INDIA EPILEPSY AND SEIZURE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 98 INDIA PARKINSON'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 99 INDIA STROKE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 100 INDIA MULTIPLE SCLEROSIS IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 101 INDIA BRAIN TUMOR IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 102 INDIA BRAIN MRI SCAN MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 103 INDIA BRAIN MRI SCAN MARKET, BY END USER, 2020-2029 (UNIT)
TABLE 104 INDIA BRAIN MRI SCAN MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 105 AUSTRALIA BRAIN MRI SCAN MARKET, BY SCANNER TYPE, 2020-2029 (USD MILLION)
TABLE 106 AUSTRALIA MID FIELD STRENGTH (1.5T MRI TO 3.0T MRI) IN BRAIN MRI SCAN MARKET, BY FIELD STRENGTH TYPE, 2020-2029 (USD MILLION)
TABLE 107 AUSTRALIA BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 108 AUSTRALIA BRAIN MRI SCAN MARKET, BY BRAIN DISORDER, 2020-2029 (USD MILLION)
TABLE 109 AUSTRALIA DEMENTIA IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 110 AUSTRALIA ALZHEIMER'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 111 AUSTRALIA EPILEPSY AND SEIZURE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 112 AUSTRALIA PARKINSON'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 113 AUSTRALIA STROKE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 114 AUSTRALIA MULTIPLE SCLEROSIS IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 115 AUSTRALIA BRAIN TUMOR IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 116 AUSTRALIA BRAIN MRI SCAN MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 117 AUSTRALIA BRAIN MRI SCAN MARKET, BY END USER, 2020-2029 (UNIT)
TABLE 118 AUSTRALIA BRAIN MRI SCAN MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 119 THAILAND BRAIN MRI SCAN MARKET, BY SCANNER TYPE, 2020-2029 (USD MILLION)
TABLE 120 THAILAND MID FIELD STRENGTH (1.5T MRI TO 3.0T MRI) IN BRAIN MRI SCAN MARKET, BY FIELD STRENGTH TYPE, 2020-2029 (USD MILLION)
TABLE 121 THAILAND BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 122 THAILAND BRAIN MRI SCAN MARKET, BY BRAIN DISORDER, 2020-2029 (USD MILLION)
TABLE 123 THAILAND DEMENTIA IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 124 THAILAND ALZHEIMER'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 125 THAILAND EPILEPSY AND SEIZURE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 126 THAILAND PARKINSON'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 127 THAILAND STROKE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 128 THAILAND MULTIPLE SCLEROSIS IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 129 THAILAND BRAIN TUMOR IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 130 THAILAND BRAIN MRI SCAN MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 131 THAILAND BRAIN MRI SCAN MARKET, BY END USER, 2020-2029 (UNIT)
TABLE 132 THAILAND BRAIN MRI SCAN MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 133 SINGAPORE BRAIN MRI SCAN MARKET, BY SCANNER TYPE, 2020-2029 (USD MILLION)
TABLE 134 SINGAPORE MID FIELD STRENGTH (1.5T MRI TO 3.0T MRI) IN BRAIN MRI SCAN MARKET, BY FIELD STRENGTH TYPE, 2020-2029 (USD MILLION)
TABLE 135 SINGAPORE BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 136 SINGAPORE BRAIN MRI SCAN MARKET, BY BRAIN DISORDER, 2020-2029 (USD MILLION)
TABLE 137 SINGAPORE DEMENTIA IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 138 SINGAPORE ALZHEIMER'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 139 SINGAPORE EPILEPSY AND SEIZURE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 140 SINGAPORE PARKINSON'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 141 SINGAPORE STROKE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 142 SINGAPORE MULTIPLE SCLEROSIS IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 143 SINGAPORE BRAIN TUMOR IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 144 SINGAPORE BRAIN MRI SCAN MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 145 SINGAPORE BRAIN MRI SCAN MARKET, BY END USER, 2020-2029 (UNIT)
TABLE 146 SINGAPORE BRAIN MRI SCAN MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 147 MALAYSIA BRAIN MRI SCAN MARKET, BY SCANNER TYPE, 2020-2029 (USD MILLION)
TABLE 148 MALAYSIA MID FIELD STRENGTH (1.5T MRI TO 3.0T MRI) IN BRAIN MRI SCAN MARKET, BY FIELD STRENGTH TYPE, 2020-2029 (USD MILLION)
TABLE 149 MALAYSIA BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 150 MALAYSIA BRAIN MRI SCAN MARKET, BY BRAIN DISORDER, 2020-2029 (USD MILLION)
TABLE 151 MALAYSIA DEMENTIA IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 152 MALAYSIA ALZHEIMER'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 153 MALAYSIA EPILEPSY AND SEIZURE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 154 MALAYSIA PARKINSON'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 155 MALAYSIA STROKE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 156 MALAYSIA MULTIPLE SCLEROSIS IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 157 MALAYSIA BRAIN TUMOR IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 158 MALAYSIA BRAIN MRI SCAN MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 159 MALAYSIA BRAIN MRI SCAN MARKET, BY END USER, 2020-2029 (UNIT)
TABLE 160 MALAYSIA BRAIN MRI SCAN MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 161 INDONESIA BRAIN MRI SCAN MARKET, BY SCANNER TYPE, 2020-2029 (USD MILLION)
TABLE 162 INDONESIA MID FIELD STRENGTH (1.5T MRI TO 3.0T MRI) IN BRAIN MRI SCAN MARKET, BY FIELD STRENGTH TYPE, 2020-2029 (USD MILLION)
TABLE 163 INDONESIA BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 164 INDONESIA BRAIN MRI SCAN MARKET, BY BRAIN DISORDER, 2020-2029 (USD MILLION)
TABLE 165 INDONESIA DEMENTIA IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 166 INDONESIA ALZHEIMER'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 167 INDONESIA EPILEPSY AND SEIZURE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 168 INDONESIA PARKINSON'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 169 INDONESIA STROKE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 170 INDONESIA MULTIPLE SCLEROSIS IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 171 INDONESIA BRAIN TUMOR IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 172 INDONESIA BRAIN MRI SCAN MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 173 INDONESIA BRAIN MRI SCAN MARKET, BY END USER, 2020-2029 (UNIT)
TABLE 174 INDONESIA BRAIN MRI SCAN MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 175 PHILIPPINES BRAIN MRI SCAN MARKET, BY SCANNER TYPE, 2020-2029 (USD MILLION)
TABLE 176 PHILIPPINES MID FIELD STRENGTH (1.5T MRI TO 3.0T MRI) IN BRAIN MRI SCAN MARKET, BY FIELD STRENGTH TYPE, 2020-2029 (USD MILLION)
TABLE 177 PHILIPPINES BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 178 PHILIPPINES BRAIN MRI SCAN MARKET, BY BRAIN DISORDER, 2020-2029 (USD MILLION)
TABLE 179 PHILIPPINES DEMENTIA IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 180 PHILIPPINES ALZHEIMER'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 181 PHILIPPINES EPILEPSY AND SEIZURE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 182 PHILIPPINES PARKINSON'S DISEASE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 183 PHILIPPINES STROKE IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 184 PHILIPPINES MULTIPLE SCLEROSIS IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 185 PHILIPPINES BRAIN TUMOR IN BRAIN MRI SCAN MARKET, BY MACHINE TYPE, 2020-2029 (USD MILLION)
TABLE 186 PHILIPPINES BRAIN MRI SCAN MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 187 PHILIPPINES BRAIN MRI SCAN MARKET, BY END USER, 2020-2029 (UNIT)
TABLE 188 PHILIPPINES BRAIN MRI SCAN MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
TABLE 189 REST OF ASIA-PACIFIC BRAIN MRI SCAN MARKET, BY SCANNER TYPE, 2020-2029 (USD MILLION)
Liste des figures
FIGURE 1 ASIA PACIFIC BRAIN MRI SCAN MARKET : SEGMENTATION
FIGURE 2 ASIA PACIFIC BRAIN MRI SCAN MARKET: DATA TRIANGULATION
FIGURE 3 ASIA PACIFIC BRAIN MRI SCAN MARKET: DROC ANALYSIS
FIGURE 4 ASIA PACIFIC BRAIN MRI SCAN MARKET: ASIA PACIFIC VS REGIONAL MARKET ANALYSIS
FIGURE 5 ASIA PACIFIC BRAIN MRI SCAN MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 ASIA PACIFIC BRAIN MRI SCAN MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 ASIA PACIFIC BRAIN MRI SCAN MARKET: DBMR POSITION GRID
FIGURE 8 ASIA PACIFIC BRAIN MRI SCAN MARKET: VENDOR SHARE ANALYSIS
FIGURE 9 ASIA PACIFIC BRAIN MRI SCAN MARKET: END USER COVERAGE GRID
FIGURE 10 ASIA PACIFIC BRAIN MRI SCAN MARKET: SEGMENTATION
FIGURE 11 NORTH AMERICA IS ANTICIPATED TO DOMINATE THE ASIA PACIFIC BRAIN MRI SCAN MARKET AND ASIA-PACIFIC IS ESTIMATED TO BE GROWING WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 INCREASED PREVALENCE OF NEUOROLOGICAL DISEASES RRISE IN TECHNOLOGICAL ADVANCEMENTS IN NON-INVASIVE BRAIN SCAN MRI DEVICES AND PRODUCT APPPROVALS IS EXPECTED TO DRIVE ASIA PACIFIC BRAIN MRI SCAN MARKET FROM 2022 TO 2029
FIGURE 13 SCANNER TYPE SEGMENT IS EXPECTED TO HAVE THE LARGEST SHARE OF THE ASIA PACIFIC BRAIN MRI SCAN MARKET FROM 2022 & 2029
FIGURE 14 TOTAL PATIENTS UNDERGOING PERIODIC HEALTH EXAMINATION USING MRI (IN MILLION0
FIGURE 15 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE ASIA PACIFIC BRAIN MRI SCAN MARKET
FIGURE 16 INCIDENCE OF ADULT ONSET BRAIN DISORDERS IN THE U.S. IN 2021
FIGURE 17 ASIA PACIFIC BRAIN MRI SCAN MARKET: BY SCANNER TYPE, 2021
FIGURE 18 ASIA PACIFIC BRAIN MRI SCAN MARKET: BY SCANNER TYPE, 2020-2029 (USD MILLION)
FIGURE 19 ASIA PACIFIC BRAIN MRI SCAN MARKET: BY SCANNER TYPE, CAGR (2022-2029)
FIGURE 20 ASIA PACIFIC BRAIN MRI SCAN MARKET: BY SCANNER TYPE, LIFELINE CURVE
FIGURE 21 ASIA PACIFIC BRAIN MRI SCAN MARKET: BY MACHINE TYPE, 2021
FIGURE 22 ASIA PACIFIC BRAIN MRI SCAN MARKET: BY MACHINE TYPE, 2020-2029 (USD MILLION)
FIGURE 23 ASIA PACIFIC BRAIN MRI SCAN MARKET: BY MACHINE TYPE, CAGR (2022-2029)
FIGURE 24 ASIA PACIFIC BRAIN MRI SCAN MARKET: BY MACHINE TYPE, LIFELINE CURVE
FIGURE 25 ASIA PACIFIC BRAIN MRI SCAN MARKET: BY BRAIN DISORDER, 2021
FIGURE 26 ASIA PACIFIC BRAIN MRI SCAN MARKET: BY BRAIN DISORDER, 2020-2029 (USD MILLION)
FIGURE 27 ASIA PACIFIC BRAIN MRI SCAN MARKET: BY BRAIN DISORDER, CAGR (2022-2029)
FIGURE 28 ASIA PACIFIC BRAIN MRI SCAN MARKET: BY BRAIN DISORDER, LIFELINE CURVE
FIGURE 29 ASIA PACIFIC BRAIN MRI SCAN MARKET: BY END USER, 2021
FIGURE 30 ASIA PACIFIC BRAIN MRI SCAN MARKET: BY END USER, 2020-2029 (USD MILLION)
FIGURE 31 ASIA PACIFIC BRAIN MRI SCAN MARKET: BY END USER, CAGR (2022-2029)
FIGURE 32 ASIA PACIFIC BRAIN MRI SCAN MARKET: BY END USER, LIFELINE CURVE
FIGURE 33 ASIA PACIFIC BRAIN MRI SCAN MARKET: BY DISTRIBUTION CHANNEL, 2021
FIGURE 34 ASIA PACIFIC BRAIN MRI SCAN MARKET: BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)
FIGURE 35 ASIA PACIFIC BRAIN MRI SCAN MARKET: BY DISTRIBUTION CHANNEL, CAGR (2022-2029)
FIGURE 36 ASIA PACIFIC BRAIN MRI SCAN MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 37 ASIA-PACIFIC BRAIN MRI SCAN MARKET: SNAPSHOT (2021)
FIGURE 38 ASIA-PACIFIC BRAIN MRI SCAN MARKET: BY COUNTRY (2021)
FIGURE 39 ASIA-PACIFIC BRAIN MRI SCAN MARKET: BY REGION (2022 & 2029)
FIGURE 40 ASIA-PACIFIC BRAIN MRI SCAN MARKET: BY REGION (2021 & 2029)
FIGURE 41 ASIA-PACIFIC BRAIN MRI SCAN MARKET: BY SCANNER TYPE (2022-2029)
FIGURE 42 ASIA PACIFIC BRAIN MRI SCAN MARKET: COMPANY SHARE 2021 (%)
Méthodologie de recherche
La collecte de données et l'analyse de l'année de base sont effectuées à l'aide de modules de collecte de données avec des échantillons de grande taille. L'étape consiste à obtenir des informations sur le marché ou des données connexes via diverses sources et stratégies. Elle comprend l'examen et la planification à l'avance de toutes les données acquises dans le passé. Elle englobe également l'examen des incohérences d'informations observées dans différentes sources d'informations. Les données de marché sont analysées et estimées à l'aide de modèles statistiques et cohérents de marché. De plus, l'analyse des parts de marché et l'analyse des tendances clés sont les principaux facteurs de succès du rapport de marché. Pour en savoir plus, veuillez demander un appel d'analyste ou déposer votre demande.
La méthodologie de recherche clé utilisée par l'équipe de recherche DBMR est la triangulation des données qui implique l'exploration de données, l'analyse de l'impact des variables de données sur le marché et la validation primaire (expert du secteur). Les modèles de données incluent la grille de positionnement des fournisseurs, l'analyse de la chronologie du marché, l'aperçu et le guide du marché, la grille de positionnement des entreprises, l'analyse des brevets, l'analyse des prix, l'analyse des parts de marché des entreprises, les normes de mesure, l'analyse globale par rapport à l'analyse régionale et des parts des fournisseurs. Pour en savoir plus sur la méthodologie de recherche, envoyez une demande pour parler à nos experts du secteur.
Personnalisation disponible
Data Bridge Market Research est un leader de la recherche formative avancée. Nous sommes fiers de fournir à nos clients existants et nouveaux des données et des analyses qui correspondent à leurs objectifs. Le rapport peut être personnalisé pour inclure une analyse des tendances des prix des marques cibles, une compréhension du marché pour d'autres pays (demandez la liste des pays), des données sur les résultats des essais cliniques, une revue de la littérature, une analyse du marché des produits remis à neuf et de la base de produits. L'analyse du marché des concurrents cibles peut être analysée à partir d'une analyse basée sur la technologie jusqu'à des stratégies de portefeuille de marché. Nous pouvons ajouter autant de concurrents que vous le souhaitez, dans le format et le style de données que vous recherchez. Notre équipe d'analystes peut également vous fournir des données sous forme de fichiers Excel bruts, de tableaux croisés dynamiques (Fact book) ou peut vous aider à créer des présentations à partir des ensembles de données disponibles dans le rapport.
